Synopsis of recent research by authors named "Tingjuan Ni"
- Tingjuan Ni's research predominantly focuses on the molecular mechanisms underlying cardiovascular diseases, particularly those related to myocardial infarction and diabetic cardiomyopathy, highlighting the role of various non-coding RNAs and signaling pathways.
- The findings reveal that targeting specific genes like Runx1 and long non-coding RNAs such as ZFAS1 and linc-ROR can mitigate cardiac dysfunction and complications associated with conditions like diabetes and doxorubicin-induced cardiotoxicity.
- Additionally, Ni's studies suggest potential therapeutic agents, including dihydromyricetin and icariin, that may offer cardioprotective effects through mechanisms such as autophagy activation and modulation of miRNA expression, thus providing insights for novel treatment strategies for heart diseases.
